MedTrace Logo

Zemedy Application for Irritable Bowel Syndrome

NCT04723056 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2025-05-28

Study results available
· View outcomes & findings →

Summary

The purpose of the study is investigate the effectiveness of Zemedy, a mobile application that enables the digital delivery of a CBT program to people with IBS.

Conditions

  • IBS - Irritable Bowel Syndrome

Interventions

DEVICE

Use of Zemedy Application

8 weeks of CBT via the Zemedy Application.

Sponsors & Collaborators

Principal Investigators

  • Linda Nguyen, MD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-15
Primary Completion
2024-03-08
Completion
2024-03-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04723056 on ClinicalTrials.gov